Oguz Bakkal is a seasoned finance professional with extensive experience in financial planning and analysis, and strategic finance within the pharmaceutical and healthcare industries. Currently serving as Vice President of Financial Planning & Analysis at Revolution Medicines since August 2025, Oguz has held key roles at Ionis Pharmaceuticals, Inc., and Seagen, where responsibilities included leading commercial and strategic finance efforts. Prior experience includes significant positions at McKinsey & Company, Bayer, and ZS, complemented by expertise in marketing strategy from Ford Motor Company. Oguz holds an MBA from The University of Chicago Booth School of Business and a Bachelor's degree in Management from Bilkent University.
This person is not in any teams
This person is not in any offices